State of Tennessee, Treasury Department - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
State of Tennessee, Treasury Department ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$985,290
-23.6%
21,424
-4.5%
0.00%
-20.0%
Q2 2023$1,288,823
+65.7%
22,426
+8.1%
0.01%
+66.7%
Q1 2023$777,975
+104186.2%
20,746
-22.1%
0.00%0.0%
Q4 2022$746
-0.3%
26,6390.0%0.00%
-25.0%
Q3 2022$748
-99.9%
26,639
-4.4%
0.00%0.0%
Q2 2022$969,000
+94.2%
27,867
+100.6%
0.00%
+100.0%
Q1 2022$499,000
+81.5%
13,895
+17.9%
0.00%
+100.0%
Q4 2021$275,000
+22.2%
11,7890.0%0.00%0.0%
Q3 2021$225,000
-14.4%
11,789
-9.6%
0.00%0.0%
Q2 2021$263,000
+10.0%
13,0450.0%0.00%0.0%
Q1 2021$239,000
-5.9%
13,045
+3.5%
0.00%0.0%
Q4 2020$254,000
+18.1%
12,609
+9.7%
0.00%0.0%
Q3 2020$215,000
-16.7%
11,4930.0%0.00%0.0%
Q2 2020$258,000
+41.0%
11,493
-6.6%
0.00%0.0%
Q1 2020$183,000
-22.8%
12,3030.0%0.00%0.0%
Q4 2019$237,000
-63.3%
12,303
-62.2%
0.00%
-66.7%
Q3 2019$646,000
+101.2%
32,577
+114.1%
0.00%
+50.0%
Q2 2019$321,000
+6.6%
15,218
+3.3%
0.00%
+100.0%
Q1 2019$301,000
-25.9%
14,725
-27.9%
0.00%
-50.0%
Q4 2018$406,000
+6.3%
20,423
+2.9%
0.00%0.0%
Q3 2018$382,0000.0%19,853
-20.8%
0.00%0.0%
Q2 2018$382,000
-21.4%
25,065
-3.4%
0.00%0.0%
Q1 2018$486,000
-12.0%
25,941
-9.5%
0.00%0.0%
Q4 2017$552,000
-2.8%
28,665
-9.8%
0.00%
-33.3%
Q3 2017$568,000
-6.0%
31,786
-5.9%
0.00%0.0%
Q2 2017$604,000
+23.3%
33,7950.0%0.00%
+50.0%
Q1 2017$490,000
-0.2%
33,795
+26.7%
0.00%
-33.3%
Q4 2016$491,000
-3.0%
26,6750.0%0.00%
+50.0%
Q3 2016$506,00026,6750.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders